Study rationale and design of the PEOPLHE trial
Purpose Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20–40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth” (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities. Methods PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50–75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support. Conclusion The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:129 |
|---|---|
| Enthalten in: |
La Radiologia medica - 129(2024), 3 vom: 06. Feb., Seite 411-419 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Milanese, Gianluca [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| BKL: | |
|---|---|
| Themen: |
Low-dose computed tomography |
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1007/s11547-024-01764-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055169007 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055169007 | ||
| 003 | DE-627 | ||
| 005 | 20240316064729.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240316s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11547-024-01764-4 |2 doi | |
| 035 | |a (DE-627)SPR055169007 | ||
| 035 | |a (SPR)s11547-024-01764-4-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.64 |2 bkl | ||
| 100 | 1 | |a Milanese, Gianluca |e verfasserin |0 (orcid)0000-0003-1974-4854 |4 aut | |
| 245 | 1 | 0 | |a Study rationale and design of the PEOPLHE trial |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Purpose Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20–40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth” (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities. Methods PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50–75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support. Conclusion The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems. | ||
| 650 | 4 | |a Lung cancer |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Lung cancer screening |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Low-dose computed tomography |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Lung-RADS |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Primary and secondary prevention |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Silva, Mario |0 (orcid)0000-0002-2538-7032 |4 aut | |
| 700 | 1 | |a Ledda, Roberta Eufrasia |0 (orcid)0000-0003-3184-2676 |4 aut | |
| 700 | 1 | |a Iezzi, Elisa |0 (orcid)0000-0002-6288-2999 |4 aut | |
| 700 | 1 | |a Bortolotto, Chandra |0 (orcid)0000-0002-9193-9309 |4 aut | |
| 700 | 1 | |a Mauro, Letizia Antonella |4 aut | |
| 700 | 1 | |a Valentini, Adele |4 aut | |
| 700 | 1 | |a Reali, Linda |4 aut | |
| 700 | 1 | |a Bottinelli, Olivia Maria |4 aut | |
| 700 | 1 | |a Ilardi, Adriana |4 aut | |
| 700 | 1 | |a Basile, Antonio |4 aut | |
| 700 | 1 | |a Palmucci, Stefano |0 (orcid)0000-0002-7196-2974 |4 aut | |
| 700 | 1 | |a Preda, Lorenzo |0 (orcid)0000-0002-5479-2766 |4 aut | |
| 700 | 1 | |a Sverzellati, Nicola |0 (orcid)0000-0002-4820-3785 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t La Radiologia medica |d Springer Milan, 2006 |g 129(2024), 3 vom: 06. Feb., Seite 411-419 |w (DE-627)SPR020673884 |w (DE-600)2225828-0 |x 1826-6983 |7 nnns |
| 773 | 1 | 8 | |g volume:129 |g year:2024 |g number:3 |g day:06 |g month:02 |g pages:411-419 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11547-024-01764-4 |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.64 |q VZ |
| 951 | |a AR | ||
| 952 | |d 129 |j 2024 |e 3 |b 06 |c 02 |h 411-419 | ||